ViGeneron announces research collaboration with Daiichi Sankyo to evaluate vgAAV for novel ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. ViGeneron announces research collaboration with Daiichi Sankyo to evaluate vgAAV for novel ... ViGeneron GmbHJanuary 18, 2021 GMT MUNICH, Germany, Jan. 18, 2021 (GLOBE NEWSWIRE) -- ViGeneron GmbH, a gene therapy company, today announced a research collaboration to utilize its novel engineered adeno-associated virus (vgAAV) vectors with Daiichi Sankyo Company, Limited (“Daiichi Sankyo”), for delivering a novel therapeutic protein to address an undisclosed target in a highly prevalent ophthalmic d...